Strong Revenue Growth
Q4 2024 total revenue growth of 28%, which is 4 times the market, and full-year 2024 total revenue of $612 million, representing a 27% increase.
Profitability Expansion
Q4 operating profit marked the first since the company's transformation, with adjusted EBITDA of $21 million, equating to a 12% margin and an improvement of over 1,000 basis points year-over-year.
Positive Cash Flow
First quarter of positive cash flow since the transformation, generating $9 million in free cash flow for Q4.
Growth in Surgical Revenue
Surgical revenue grew 29% in 2024, driven by a 19% increase in procedure volume and an 8% increase in average revenue per procedure.
International Expansion
First cases performed in Japan, marking an entry into the second-largest market in the world.
New Product Launch
Launch of EOS Insight software and a record EOS order book in dollars, indicating strong demand and future growth potential.